Skip to main content

Closed

ZVRA: Zevra Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-39.9%

ROIC-19.6%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-6.3×

Current ratio4.89×

Valuation

Unrated

P/E ratio4.4×

Zevra Therapeutics, Inc.

ZVRANASDAQ Global Select·USD·Closed

Zevra Therapeutics, Inc.

ZVRANASDAQ·USD·Closed

$9.51

−1.35%

$9.51

−$0.13 (1.35%)

52W Range

30thpctl

Volume

0.52×avg

Mkt Cap

562.18MUSD

P/E

4.4TTM

Div Yield

–ann

52W Range

30thpctl

Volume

0.52×avg

Market Cap

562.18MUSD

P/E Ratio

4.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings